Investment
Features
FeesSafety
Academy
More
Pluang+

Gas prices likely to stay above $3.50 through Nov amid US-Iran tensions, traders say

Market News
09 Jul 2026
CNBC
View Source
Bullish
pluang ai news

Due to renewed conflict between the U.S. and Iran, traders on Kalshi predict a 75% chance that gas prices will remain above $3.50 per gallon by November 3, with a 39% chance prices exceed $3.75. This marks a significant increase from before the conflict when prices were below $3 per gallon. The ongoing instability in the Strait of Hormuz and rising oil prices, which recently hit $75 per barrel, are key factors driving these expectations. However, traders see only a 43% chance that prices will surpass the 2026 high of $4.60 per gallon this year, indicating some caution despite the current volatility.

More News

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.

Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...

Analyst Insights
Bearish
1 hour ago
Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured

Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...

Market News
Bullish
2 hours ago
Life360 director Morin Brit sells 15,582 shares for $1 million

Life360 director Morin Brit sells 15,582 shares for $1 million

Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...

Market News
Bearish
2 hours ago
AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.

AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.

AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...

Market News
Bullish
2 hours ago
TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App